Fintel reports that on January 10, 2025, Stifel downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to Hold ...

Fintel reports that on January 10, 2025, Jefferies downgraded their outlook for IGM Biosciences (NasdaqGS:IGMS) from Buy to ...

The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as ...

IGM Biosciences Inc. said Thursday it is cutting 73% of its workforce after deciding to halt further development of a program relating to its autoimmunity-drug pipeline, sending its stock down 69% in ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

eMBR Genomics Partners with Axio BioPharma to Make MKLP1 ProTM Antibodies Commercially Available ...

MBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available: Madison, Wisconsin Tuesday, January 7, 2025, 15:00 Hrs [IST] In a milestone for cel ...

The COVID-19 pandemic revealed the devastating impact of global diseases. As the world recovers, experts warn of new and re-emerging threats like HMPV, measles, dengue, bird flu, and more. With over ...

ANSWER: When a person is taken care of by multiple providers, there is always the risk that nobody is looking at the whole person's history, and medication interactions are among the many problems ...